ClinicalTrials.Veeva

Menu

Single Site Versus Multi Site Robotic Hysterectomy

H

Herning Hospital

Status

Withdrawn

Conditions

Rehabilitation
Pain, Postoperative
Wound Infection

Treatments

Procedure: Robotic assisted hysterectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT03662451
Single site robot study

Details and patient eligibility

About

Robotic single site surgery (R-SSH) is a novel technique, which may be superior to multi site hysterectomy (R-MSH) in select patients regarding cosmesis and postoperative pain. A randomized trial is performed to compare R-SSH with R-MSH with regard to the postoperative rehabilitation, cosmesis, the operational cost, and the perioperative morbidity.

Full description

The study is scheduled to start November 2018 and compares robotic single site to multi site hysterectomy. Procedures are performed on two locations, Herning and Herlev Hospitals, by experienced surgeons. Patients are randomized to either R-SSH (No.=62) or R-MSH (No.=62). Patient's satisfaction with body image and cosmesis is assessed at different time points pre- and postoperatively by means of validated cosmesis scales and Body Image Questionnaire and photo-evaluations.

Postoperative pain and split times spent at the operation theatre will be registered as secondary outcome parameters.

A follow-up at 1, 3 and 6 month include evaluation of the scar and registration of port-site hernias and vaginal dehiscence or other complications. Interviews and diaries will include time of return to home and work, daily activities including sexuality The R-SSH is performed using da Vinci, Xi robotic system. One single port, diameter 2 cm is applied. Applying an additional assistant port is defined conversion of procedure R-MSH is performed using standard equipment and 4 trocars, 5 mm each.

Sample size calculation was based a previous study on fast track hysterectomy, which showed a difference in return to work of 4 days. 62 women in each group is needed with standard deviation ±8 and a power of 80%. To include those not working, the calculation was performed with an expected visual analog pain score of 0.86 ±0.2 and 62 in each group and suggested that the sample was sufficient to detect of difference of 0.1 in visual analog pain score with a power of 80%. All calculation are based on two-sided testing with alpha of 0.05.

Sex

Female

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hysterectomy on benign indication,
  • American Society of Anesthetists group 1 or 2,
  • BMI less than 30 kg/m2
  • uterine size less than 300 g estimated by ultrasound, using Ferraris formula.

Exclusion criteria

  • adhesions
  • prior extensive abdominal surgery
  • prior midline incision
  • cutis laxa of abdomen surgery
  • endometriosis
  • more than 1 cesarean section
  • malignant disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Robotic single-site hysterectomy
Active Comparator group
Description:
Robotic single-site hysterectomy is performed in this arm
Treatment:
Procedure: Robotic assisted hysterectomy
Robotic multi-site hysterectomy
Active Comparator group
Description:
Robotic multi-site hysterectomy is performed in this arm
Treatment:
Procedure: Robotic assisted hysterectomy

Trial contacts and locations

1

Loading...

Central trial contact

Carsten Byrialsen; Finn F Lauszus, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems